Archive
All News
Every briefing, headline, and filing we've published, newest first.
The WeekBioPharma Dive ↗
The endorsement of an advisory committee positions Moderna to complete a dramatic turnaround for a shot the FD…
The WeekBioPharma Dive ↗
The biotech is advancing an anti-inflammatory drug that originated with vTv for inflammatory bowel diseases, l…
The WeekBioPharma Dive ↗
The companies didn't specify the drugs Biogen is acquiring in the deal, though patents RayThera secured provid…
The WeekFiercePharma ↗
Four years after Spero Therapeutics received a complete response letter from the FDA, rejecting its oral treat…
The WeekFierceBiotech ↗
F2G and Shionogi have released phase 3 data for the oral antifungal drug olorofim, demonstrating its non-infer…
The WeekBriefing
Regulators appear receptive to Moderna's flu vaccine, UniQure prepares a Huntington's filing, and Lilly announ…
The WeekSTAT News ↗
A wide gap exists between what Patrick Soon-Shiong says his cancer drugs can achieve and what they actually do…
The WeekDrug Channels ↗
Today's guest post comes from Nareda Mills, President of Patient Solutions at Inizio Engage. Nareda examines h…
The WeekDrug Channels ↗
Today's guest post comes from Nareda Mills, President of Patient Solutions at Inizio Engage. Nareda examines h…
The WeekPharmaVoice ↗
Vedana Therapeutics recently emerged from stealth with $46 million to support its mission of developing "anti-…
The WeekBioPharma Dive ↗
Including the heart drug developer's offering, four biotechs in 2026 have raised at least $400 million in IPO …
The WeekAJMC ↗
Study Finds Flaw in Method for Key Oncology Value-Based Care Model…
The WeekFiercePharma ↗
With pharma and life sciences deal values surpassing $65 billion in the first quarter, marking the strongest q…
The WeekFierceBiotech ↗
With a panel of outside experts set to weigh in Thursday-and with a refusal-to-file fiasco with the FDA just b…
The WeekBriefing
Starting next month, Medicare will offer weight loss drug coverage through a temporary program that observers …
The WeekDrug Channels ↗
By Bryce Platt, PharmD Summer officially starts this weekend! Consider doing a few of your lifting sets (or wo…
The WeekBioPharma Dive ↗
Vedana Therapeutics emerged from stealth Wednesday with $46 million to support its mission of developing "anti…
The WeekSTAT News ↗
Should the federal government try to slow - or even block - U.S. biotech deals that could benefit China?…
The WeekAJMC ↗
HDV Combo Shows No Relapses at 2 Years: Tarik Asselah, MD, PhD…
The WeekPharmaVoice ↗
It's like "Rituxan all over again," said CEO Richard Miller who believes Corvus' lead candidate could make an …
The WeekFiercePharma ↗
Following criticism from drugmakers, Germany has scrapped its plan to install a program that would have reduce…
The WeekFierceBiotech ↗
The company's SPY002 prompted a 10.7-point reduction from baseline levels in patients' Robart's Histopathology…
The WeekBriefing
The FDA approved Colorado’s proposal to import certain Canadian drugs, aiming to curb costs for state resident…
The WeekDrug Channels ↗
By Bryce Platt, PharmD For years, Medicare Part D plans often preferred high-list/high-rebate branded multiple…
The Insider - Weekly pharma intelligence
Deals, negotiations, and policy analysis. Delivered when it matters.
No sponsored content. No noise. Unsubscribe anytime.